Cheaper cancer medication: Kerala HC ruling is an opportunity for Centre to take the lead

What happened: On September 26 the Kerala High Court heard Re Exorbitant Pricing of Life Saving Patented Medicines vs Union of India, concerning access to two patented breast cancer medicines, ribociclib and abemaciclib. Why it matters: The judgment is significant for its reading of Section 100 of the Patents Act, which addresses governmental use of patented inventions. The court ruled the provision extends beyond the point described in the excerpt.

On September 26 the Kerala High Court heard Re Exorbitant Pricing of Life Saving Patented Medicines vs Union of India, concerning access to two patented breast cancer medicines, ribociclib and abemaciclib.

The judgment is significant for its reading of Section 100 of the Patents Act, which addresses governmental use of patented inventions. The court ruled the provision extends beyond the point described in the excerpt.